News

Filter News By

Clear Filters

  1. Golf Enthusiasts and Celebrities Raise $750K at the 24th Annual Ultimate Golf Experience

    December 4, 2018

    The 24th annual Ultimate Golf Experience brought together a standout array of entertainers, guests, and friends of the Cystic Fibrosis Foundation for a premier golfing event to raise funds in the fight against cystic fibrosis.

  2. Positive Late Stage Study Results for Next-Generation, Triple-Combination Modulator

    November 27, 2018

    Today, Vertex Pharmaceuticals Inc. released the initial Phase 3 clinical trial data for one of two next-generation, triple-combination modulators currently being tested.

  3. Doing Well by Doing Good: Mastercard Ranks as Top Corporate Sponsor for the Greater New York Chapter

    November 15, 2018

    For the second year, Mastercard® becomes the Greater New York Chapter's top corporate sponsor thanks to two senior level executives personally affected by cystic fibrosis who initially connected employees to the mission of the Cystic Fibrosis Foundation.

  4. CF Foundation Announces 2018 Impact Grant Recipients

    October 10, 2018

    Recipients include eight innovative programs from around the country that serve the CF community.

    Topics:

  5. Support for Those Impacted by Hurricane Michael

    October 9, 2018

    The Cystic Fibrosis Foundation is offering two vital resources to support CF families who may be affected by Hurricane Michael.

  6. The Warren Alpert Foundation and Harvard Medical School Recognize CF Research Pioneers

    October 4, 2018

    On Oct. 4, the Warren Alpert Foundation honored five CF scientists, including Dr. Francis Collins, for their trailblazing work in CF research. The Foundation received special acknowledgement for our role in driving this progress, marking the first time that an organization has been recognized by the Alpert Foundation.

  7. Resources for Those Impacted by Hurricane Florence

    September 11, 2018

    In the wake of Hurricane Florence, the Cystic Fibrosis Foundation is offering two vital resources to support CF families affected by this hurricane and its surge.

  8. FDA Approves Kalydeco® for Children With CF Ages 1 to 2

    August 15, 2018

    Today, the U.S. Food and Drug Administration approved the use of ivacaftor (Kalydeco®) for children with cystic fibrosis ages 1 to 2 who have at least one mutation that is responsive to ivacaftor.

    Topics:

  9. FDA Expands Use of Orkambi® to Children With CF Ages 2 to 5

    August 7, 2018

    The U.S. Food and Drug Administration approved the use of lumacaftor/ivacaftor (Orkambi®) today for children with cystic fibrosis ages 2 to 5 who have two copies of the F508del mutation.

  10. CF Foundation Responds to Final Short-Term, Limited-Duration Health Insurance Rule

    August 2, 2018

    Yesterday, the U.S. Department of Health and Human Services finalized a rule expanding short-term, limited-duration insurance plans -- threatening access to adequate, affordable coverage for people with cystic fibrosis who rely on the individual marketplace.

  11. Drug Shows Promise in Reducing Inflammation in People With Cystic Fibrosis

    August 2, 2018

    Celtaxsys Inc. reported promising results today from an early stage clinical trial of a potential anti-inflammatory drug for people with cystic fibrosis.

  12. CF Teen Advocates Visit Capitol Hill for 10th Annual Teen Advocacy Day

    July 5, 2018

    More than 200 advocates from 32 states traveled to Washington, D.C., on June 28 for the Cystic Fibrosis Foundation’s 10th annual Teen Advocacy Day, which enabled teens to meet with their elected officials on Capitol Hill to fight for access to high-quality, specialized care for their friends and loved ones living with CF.

    Topics:

More Posts View All Posts

Follow Us On